MacroGenics | MGNX - Selling And Administration Expenses

Stock Price
1.73
Daily Change
-0.02 -1.14%
Monthly
0.58%
Yearly
-39.30%
Q1 Forecast
1.77

MacroGenics reported $9.9M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.25B 40M Jun/2025
Amgen USD 1.7B 9M Sep/2025
AstraZeneca USD 148M 4.86B Sep/2025
Biogen USD 545.2M 38.6M Sep/2025
Bristol-Myers Squibb USD 1.79B 76M Sep/2025
Daiichi Sankyo JPY 228.23B 39.15B Dec/2025
Eli Lilly USD 2.74B 12.3M Sep/2025
Genmab DKK 144M 18M Jun/2025
Geron USD 39M 437K Sep/2025
Gilead Sciences USD 1.35B 6M Sep/2025
J&J USD 6.75B 831M Dec/2025
MacroGenics USD 9.9M 600K Sep/2025
Merck USD 2.63B 0 Sep/2025
Pfizer USD 3.19B 209M Sep/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Xencor USD 87.78M 72.66M Sep/2025